Who may benefit from donor leucocyte infusions after allogeneic stem cell transplantation?
Annotation
Stephen Mackinnon,
Corresponding Author
Stephen Mackinnon
Department of Haematology,98 Chenies Mews,University College London Hospitals,London WCE1 HX6, UK
Stephen Mackinnon, Department of Haematology, Chenies Mews, University College London Hospitals, London WCE 1HX, UK. E-mail: [email protected]Search for more papers by this authorStephen Mackinnon,
Corresponding Author
Stephen Mackinnon
Department of Haematology,98 Chenies Mews,University College London Hospitals,London WCE1 HX6, UK
Stephen Mackinnon, Department of Haematology, Chenies Mews, University College London Hospitals, London WCE 1HX, UK. E-mail: [email protected]Search for more papers by this author
References
- Antin, J.H. (1993) Graft-versus-leukemia: no longer an epiphenomenon. Blood, 82, 2273 2277.
- Apperley, J.F., Jones, L., Hale, G., Waldmann, H., Hows, J., Rombos, Y., Tsatalas, C., Marcus, R.E., Goolden, A.W.G., Gordon-Smith, E.C., Catovsky, D., Galton, D.A.G., Goldman, J.M. (1986) Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft versus host disease but may increase the risk of leukaemic relapse. Bone Marrow Transplantation, 1, 53 68.
- Bar, B.M.A.M., Schattenberg, A., Mensink, E.J.B.M., Geurts van Kessel, A., Smetsers, T.F.C.M., Knops, G.H.J.N., Linders, E.H.P., De Witte, T. (1994) Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 11, 513 519.
- Bertz, H., Burger, J.A., Kunzmann, R., Mertelsmann, R., Finke, J. (1997) Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect. Leukemia, 11, 281 283.
- Cross, N.C.P., Feng, L., Chase, A., Bungey, J., Hughes, T.P., Goldman, J.M. (1993) Competitive polymerase chain reaction to estimate the number of BCR–ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood, 82, 1929 1936.
- Drobyski, W.R., Keever, C.A., Roth, M.S., Koethe, S., Hanson, G., McFadden, P., Gottschall, J.L., Ash, R.C., Van Tuinen, P., Horowitz, M.M., Flomenberg, N. (1993) Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood, 82, 2310 2318.
- Falkenburg, J.H., Wafelman, A.R., Joosten, P., Smit, W.M., Van Bergen, C.A., Bongaerts, R., Lurvink, E., Van Der Hoorn, M., Kluck, P., Landegent, J.E., Kluin-Nelemans, H.C., Fibbe, W.E., Willemze, R. (1999) Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood, 94, 1201 1208.
- Fialkow, P.J., Gartler, S.M., Yoshida, A. (1967) Clonal origin of chronic myelocytic leukemia in man. Proceedings of the National Academy of Sciences of the United States of America, 58, 1468 1471.
- Garicochea, B., Chase, A., Lazaridou, A., Goldman, J.M. (1994) T-lymphocytes in CML: no evidence of the BCR/ABL fusion gene detected by fluorescence in situ hybridization in 14 patients. Leukemia, 8, 1197 1201.
- Giralt, S., Hester, J., Huh, Y., Hirsch Ginsberg, C., Rondon, G., Seong, D., Lee, M., Gajewski, J., Van Besien, K., Khouri, I., Mehra, R., Przepiorka, D., Talpaz, M., Kantarjian, H., Fischer, H., Deisseroth, A., Champlin, R. (1995) CD8-depleted donor lymphocyte infusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Blood, 86, 4337 4343.
- Helg, C., Roux, E., Beris, P., Cabrol, C., Wacker, P., Darbellay, R., Wyss, M., Jeannet, M., Chapuis, B., Roosnek, E. (1993) Adoptive immunotherapy for recurrent CML after BMT. Bone Marrow Transplantation, 12, 125 129.
- Hertenstein, B., Wiesneth, M., Novotny, J., Bunjes, D., Stefanic, M., Heinze, B., Hubner, G., Heimpel, H., Arnold, R. (1993) Interferon-α and donor buffy coat transfusions for treatment of relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation. Transplantation, 56, 1114 1118.
- Horowitz, M.M., Gale, R.P., Sondel, P.M., Goldman, J.M., Kersey, J., Kolb, H.J., Rimm, A.A., Ringden, O., Rozman, C., Speck, B., Truitt, R.L., Zwaan, F.E., Bortin, M.M. (1990) Graft-versus-leukemia reactions following bone marrow transplantation in humans. Blood, 75, 555 562.
- Johnson, B.D., Drobyski, W.R., Truitt, R.L. (1993) Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplantation, 11, 329 336.
- Kaminski, E., Sharrock, C., Hows, J., Ritter, M., Arthur, C., Mackinnon, S., Batchelor, J.R. (1988) Frequency analysis of cytotoxic lymphocyte precursors – possible relevance to HLA-matched unrelated donor bone marrow transplantation. Bone Marrow Transplantation, 3, 149 165.
- Kaminski, E., Hows, J., Man, S., Brookes, P., Mackinnon, S., Hughes, T., Avakian, O., Goldman, J.M., Batchelor, J.R. (1989) Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation, 48, 608 613.
- Kernan, N.A., Collins, N.H., Juliano, L., Cartagena, T., Dupont, B., O'Reilly, R.J. (1986) Clonable T lymphocytes in T-cell depleted bone marrow transplants correlate with development of graft versus host disease. Blood, 68, 770 773.
- Kolb, H.J. (1998) Donor leukocyte transfusions for treatment of leukemic relapse after bone marrow transplantation. EBMT Immunology and Chronic Leukemia Working Parties. Vox Sanguinis, 74, 321 329.
- Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M., Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 2462 2465.
- Kolb, H.J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., Van Rhee, F., Mittermueller, J., De Witte, T., Holler, E., Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood, 86, 2041 2050.
- Kolb, H.J., Mittermuller, J., Holler, E., Thalmeier, K., Bartram, C.R. (1996) Graft-versus-host reaction spares normal stem cells in chronic myelogenous leukemia. Bone Marrow Transplantation, 17, 449 452.
- Kwak, L.W., Taub, D.D., Duffey, P.L., Bensinger, W.I., Bryant, E.M., Reynolds, C.W., Longo, D.L. (1995) Transfer of myeloma idiotype-specific immunity from an actively immunized marrow donor. Lancet, 345, 1016.
- Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L., Verdonck, L.F. (1997) Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 4206 4211.
- Mackinnon, S., Hows, J.M., Goldman, J.M. (1990) In vitro induction of graft-versus-leukemia activity following bone marrow transplantation for chronic myeloid leukemia. Blood, 76, 2037 2045.
- Mackinnon, S., Barnett, L., Heller, G., O'Reilly, R.J. (1994) Minimal residual disease is more common in patients who have mixed T-cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood, 83, 3409 3416.
- Mackinnon, S., Papadopoulos, E.P., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W., O'Reilly, R.J. (1995) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia following bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 1261 1268.
- Mackinnon, S., Barnett, L., Heller, G. (1996) Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia. Bone Marrow Transplantation, 17, 643 647.
- Mandigers, C.M., Meijerink, J.P., Raemaekers, J.M., Schattenberg, A.V., Mensink, E.J. (1998) Graft-versus-lymphoma effect of donor leucocyte infusion shown by real- time quantitative PCR analysis of t (14;18) (Letter). Lancet, 352, 1522 1523.
- Mehta, J. & Singhal, S. (1998) Graft-versus-myeloma. Bone Marrow Transplantation, 22, 835 843.
- Nimer, S.D., Giorgi, J., Gajewski, J.L., Ku, N., Schiller, G.J., Lee, K., Territo, M., Ho, W., Feig, S., Selch, M., Isacescu, V., Reichert, T.A., Champlin, R.E. (1994) Selective depletion of CD8+ cells for prevention of graft-versus-host disease after bone-marrow transplantation – a randomized controlled trial. Transplantation, 57, 82 87.
- Papadopoulos, E.B., Ladanyi, M., Emanuel, D., Mackinnon, S., Boulad, F., Carabasi, M.H., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Small, T.N., Young, J.W., Kernan, N.A., O'Reilly, R.J. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. New England Journal of Medicine, 330, 1185 1191.
- Pati, A.R., Godder, K., Parrish, R., Abhyankar, S., Chiang, K.Y., Lee, C., Mauldin, K., Gee, A.P., Henslee-Downey, P.J. (1996) Pre-emptive therapy with donor leukocyte infusions to prevent relapse following partially mismatched related donor bone marrow transplantation (Abstract). Blood, 88, 259a.
- Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L.M., Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100 106.
- Schwarer, A.P., Jiang, Y.Z., Brookes, P.A., Barrett, A.J., Batchelor, J.R., Goldman, J.M., Lechler, R.I. (1993) Frequency of anti-recipient alloreactive helper T-cell precursors in donor blood and graft-versus-host disease after HLA-identical sibling bone marrow transplantation. Lancet, 341, 203 205.
- Slavin, S., Naparstek, E., Nagler, A., Ackerstein, A., Samuel, S., Kapelushnik, J., Brautbar, C., Or, R. (1996) Allogeneic cell therapy with donor peripheral blood cells and recombinant human interleukin-2 to treat leukemia relapse after allogeneic bone marrow transplantation. Blood, 87, 2195 2204.
- Smit, W.M., Rijnbeek, M., Van Bergen, C.A., Willemze, R., Falkenburg, J.H. (1998) Generation of leukemia-reactive cytotoxic T lymphocytes from HLA-identical donors of patients with chronic myeloid leukemia using modifications of a limiting dilution assay. Bone Marrow Transplantation, 21, 553 560.
- Theobald, M., Nierle, T., Bunjes, D., Arnold, R., Heimpel, H. (1992) Host-specific interleukin-2-secreting donor T-cell precursors as predictors of acute graft-versus-host disease in bone marrow transplantation between HLA-identical siblings. New England Journal of Medicine, 327, 1613 1617.
- Van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C.P., Chase, A., Garicochea, B., Bungey, J., Barrett, J., Goldman, J.M. (1994) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 3377 3383.
- Van Rhee, F., Savage, D., Blackwell, J., Orchard, K., Dazzi, F., Lin, F., Chase, A., Bungey, J., Cross, N.C., Apperley, J., Szydlo, R., Goldman, J.M. (1998) Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors. Bone Marrow Transplantation, 21, 1055 1061.
- Weiden, P.L., Flournoy, N., Thomas, E.D., Prentice, R., Fefer, A., Buckner, C.D., Storb, R. (1979) Antileukemic effect of graft versus host disease in recipients of allogeneic marrow grafts. New England Journal of Medicine, 300, 1068 1073.
- Weiss, L., Reich, S., Slavin, S. (1992) Use of recombinant human interleukin-2 in conjunction with bone marrow transplantation as a model for control of minimal residual disease in malignant hematological disorders. I. Treatment of murine leukemia in conjunction with allogeneic bone marrow transplantation and IL-2-activated cell-mediated immunotherapy. Cancer Investigation, 10, 19 26.
- Young, J.L., Percy, C.L., Asire, A.J. (1981) Surveillance epidemiology and results, incidence and mortality data: 1973–77. National Cancer Institute Monograph, 57, 91 95.
Citing Literature
